A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 are Tolerated and Act in the Body of Healthy Adults
C6341001
Phase 1 other active
Quick answer
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 are Tolerated and Act in the Body of Healthy Adults for Rheumatoid arthritis and Systemic Lupus Erythematosus is a Phase 1 program (other) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Rheumatoid arthritis and Systemic Lupus Erythematosus
- Phase
- Phase 1
- Modality
- other
- Status
- active